Visugromab Antibody

SKU: orb1943900

Description

Visugromab (CTL-002) is a GDF-15-neutralizing monoclonal antibody. It demonstrates synergistic antitumor efficacy in combination with anti-PD-1 therapy like Nivolumab, showing promise in preclinical models for treating PD-1/PD-L1 refractory metastatic cancers.

Research Area

Cell Biology, Immunology & Inflammation, Stem Cell & Developmental Biology

Images & Validation

−

Key Properties

−

Antibody Type	Inhibitor Antibody
Clonality	Monoclonal
Target	TGF-beta/Smad,PD-1/PD-L1
Molecular Weight	144.50 kDa
Purity	95.00% (May vary between batches)
Conjugation	Unconjugated

Storage & Handling

−

Storage	Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Concentration	5 mg/mL
Expiration Date	12 months from date of receipt.
Disclaimer	For research use only

Alternative Names

−

PDL1, PD-L1, CTL002, CTL-002, PD1/PDL1, PD1, PD-1

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Quick Database Links

Gene Symbol

TGF-beta/Smad,PD-1/PD-L1

Documents Download

Datasheet

Product Information

Download

Request a Document

Protocol Information

Find More Protocols